Clinical Trial Update: Efficacy and Safety of Milnacipran in the Treatment of Fibromyalgia in an Elderly Population [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating milnacipran for fibromyalgia in an elderly population was terminated. The update summarizes observed efficacy and safety in the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia

Drugs mentioned

• SAVELLA (milnacipran hydrochloride)

Snippet

Sponsor: Banner Health | Conditions: Fibromyalgia | Phase 3 | Status: TERMINATED